Journal of thrombosis and thrombolysis
Journal
Overview
publication venue for
-
Management and outcomes of women with antiphospholipid syndrome during pregnancy.
2023
-
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial..
55.
2022
-
Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism.
2022
-
Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis..
51.
2021
-
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients..
52.
2021
-
Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey..
50.
2020
-
The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic..
52.
2020
-
Risk factors for intracerebral hemorrhage in patients with COVID-19..
51.
2020
-
Right ventricular strain in patients with pulmonary embolism and syncope..
50.
2020
-
Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience..
48.
2019
-
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis..
48.
2019
-
A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures..
46.
2018
-
Does my patient have a pulmonary embolism? The Wells vs. PISA 2 rule in orthopedic patients..
45.
2018
-
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial..
45.
2018
-
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy..
44.
2017
-
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study..
43.
2017
-
Use of signals and systems engineering to improve the safety of warfarin initiation..
42.
2016
-
Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience..
42.
2016
-
Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection..
42.
2016
-
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials..
40.
2015
-
EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy..
36.
2013
-
Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting..
36.
2013
-
Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention..
35.
2013
-
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil..
34.
2012
-
Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo..
34.
2012
-
Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials..
34.
2012
-
Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness..
33.
2012
-
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil..
32.
2011
-
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design..
32.
2011
-
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome..
31.
2011
-
Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro..
30.
2010
-
Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent..
29.
2010
-
Reconstructed 4-chamber views compared with axial imaging for assessment of right ventricular enlargement on CT pulmonary angiograms..
28.
2009
-
Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples..
28.
2009
-
Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery..
24.
2007
-
Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative..
21.
2006
-
The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction..
21.
2006
-
Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model..
19.
2005
-
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee..
19.
2005
-
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor..
18.
2004
-
Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study..
18.
2004
-
Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture..
15.
2003
-
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A..
14.
2002
-
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction..
9.
2000
-
Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro..
9.
2000
-
Platelet Inhibition in Cardiovascular Disease Management: Aspirin and Beyond..
5 Suppl 1.
1998
-
Adjunctive Antiplatelet Therapy in Acute Myocardial Infarction: The Road to Improved Infarct-Related Artery Patency..
4.
1997
-
Physicians' Use of Heparin Following Thrombolytic Therapy: An International Perspective..
4.
1997
-
Antithrombotic Therapy during Percutaneous Coronary Intervention..
2.
1995
-
Randomized, Placebo-Controlled Study of Lamifiban with Thrombolytic Therapy for the Treatment of Acute Myocardial Infarction: Rationale and Design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Study..
2.
1995
-
Implementation and impact of a multidisciplinary coagulation factor stewardship program at an academic medical center.
2020
-
Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review.
2007
-
Patient-specific antiplatelet therapy.
2004
-
Characteristics and comparisons of acute stroke in "recovered" to "active COVID-19 and "pre-pandemic" in Qatar database.
2022
-
D-Dimer elevation and adverse outcomes.
2015
-
Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs.
2009
-
Multi-bed vascular disease: past, present, and future.
2004
-
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
1999
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)